Professional Documents
Culture Documents
Prof S Kalyanaraman
OXCARBAZEPINE
OXCARBAZEPINE
OXCARBAZEPINE
OXCARBAZEPINE
3. What are the indications ? Partial seizures in adults All indications of Carbamazepine including diabetic neuropathy Trigeminal neuralgia Mood stabiliser in affective disorders
OXCARBAZEPINE
OXCARBAZEPINE
OXCARBAZEPINE
6. What is the dosage? Starting dose 300 mg bd Increase dose by 600 mg / day at weekly intervals Maximum 1200 mg bd Dosing interval twice daily
OXCARBAZEPINE
600 mg
Rs 10 / -
OXCARBAZEPINE
OXCARBAZEPINE
Better than Carbamazepine Milder side effects Fewer idiosyncratic reactions Fewer interactions with other drugs
OXCARBAZEPINE
10. What are the disadvantages ? Moderately high cost May render hormonal contraceptive ineffective May increase plasma level of Phenytoin and Phenobarbitone and these drugs may decrease oxcarbazepine level
CLONAZEPAM
CLONAZEPAM
CLONAZEPAM
CLONAZEPAM
CLONAZEPAM
CLONAZEPAM
CLONAZEPAM
Nil significant
CLONAZEPAM
CLONAZEPAM
CLONAZEPAM
CLONAZEPAM
LAMOTRIGINE
LAMOTRIGINE
Inhibits release of excitatory aminoacids especially glutamate Blocks voltage dependant sodium channel conductance
LAMOTRIGINE
LAMOTRIGINE
Dose reduction should be 50 % per week over 2 3 weeks unless safety concerns require rapid withdrawal
LAMOTRIGINE
LAMOTRIGINE
LAMOTRIGINE
(a few cases have been reported when patients who had sexual dysfunction while on AED improved with Lamotrigine)
LAMOTRIGINE
100 mg
Rs 10 / -
TOPIRAMATE
TOPIRAMATE
Multiple actions contributing to its antiepileptic potential Actions on sodium conductance, GABA - A receptor activity, glutamate receptor activity, calcium channel activity and carbonic anhydrase
TOPIRAMATE
Bioavailability 100 % Plasma elimination half life 18 30 hours Time to steady state 4 5 days Protein binding 15 % 80 % drug eliminated unchanged in urine Rest metabolised to inactive compounds in liver
TOPIRAMATE
Topiramate levels decreased by concomitant administration of carbamazepine, phenytoin and phenobarbital Phenytoin level increased by topiramate
TOPIRAMATE
Start with 25 mg / day Increase dose by 25 50 mg every fortnight Maximum dose 200 mg bd (rarely 300 mg bd)
TOPIRAMATE
TOPIRAMATE
TOPIRAMATE
TOPIRAMATE
100 mg
Rs 14 / -
TOPIRAMATE
Weight loss (especially when valproate causes weight gain) Powerful antiepileptic effect, sometimes effective when all other AEDs are ineffective
TOPIRAMATE
ZONISAMIDE
ZONISAMIDE
ZONISAMIDE
Multiple
Inhibits voltage gated sodium channel Affects T type calcium currents Affects excitatory glutaminergic transmission Binds to benzodiazepine GABA A receptor
ZONISAMIDE
ZONISAMIDE
ZONISAMIDE
Oral bioavailability < 100 % Time to peak levels 2 4 hours Elimination half life 50 70 hours Protein binding 30 60 % Biotransformation: Acetylation, Reduction, Glucuronidation Active metabolite - none
ZONISAMIDE
6. What are the drug interactions ? Half life of zonisamide reduced by phenytoin to 45 % carbamazepine to 65 % phenobarbitone to 65 % valproate to 75 %
ZONISAMIDE
Children:
Initial 2 4 mg / kg / day Maintenance 4 8 mg / kg / day
Dosing interval:
1 2 times / day Half life is long on monotherapy but considerably reduced in adjunctive therapy
ZONISAMIDE
ZONISAMIDE
ZONISAMIDE
Specially useful in Lennox Gastaut syndrome, infantile spasms, progressive myoclonic epilepsy
ZONISAMIDE
Side effects